RU92016463A - APPLICATION OF DERIVATIVES OF TISSTINES FOR THE MANUFACTURE OF MEDICINES WITH IMMUNOMODING EFFECT, PHARMACEUTICAL COMPOSITIONS ON THEIR BASIS - Google Patents
APPLICATION OF DERIVATIVES OF TISSTINES FOR THE MANUFACTURE OF MEDICINES WITH IMMUNOMODING EFFECT, PHARMACEUTICAL COMPOSITIONS ON THEIR BASISInfo
- Publication number
- RU92016463A RU92016463A RU92016463/14A RU92016463A RU92016463A RU 92016463 A RU92016463 A RU 92016463A RU 92016463/14 A RU92016463/14 A RU 92016463/14A RU 92016463 A RU92016463 A RU 92016463A RU 92016463 A RU92016463 A RU 92016463A
- Authority
- RU
- Russia
- Prior art keywords
- derivatives
- tisstines
- immunomoding
- medicines
- manufacture
- Prior art date
Links
- 239000003814 drug Substances 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 201000010099 disease Diseases 0.000 claims 2
- 210000000987 Immune System Anatomy 0.000 claims 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine zwitterion Chemical class [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
Claims (1)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9002067-8 | 1990-06-08 | ||
SE9002067A SE9002067D0 (en) | 1990-06-08 | 1990-06-08 | THE PHARMACOLOGICAL USE OF CERTAIN CYSTINE DERIVATIVES |
SE9002275-7 | 1990-06-28 | ||
SE9002275A SE9002275D0 (en) | 1990-06-28 | 1990-06-28 | NOVEL 3,3'-DITHIOBIS (PROPIONIC ACIDS) |
Publications (2)
Publication Number | Publication Date |
---|---|
RU92016463A true RU92016463A (en) | 1995-09-10 |
RU2119793C1 RU2119793C1 (en) | 1998-10-10 |
Family
ID=26660796
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU92016463A RU2119793C1 (en) | 1990-06-08 | 1991-06-03 | Substances exhibiting immunomodulating effect, pharmaceutical composition based on thereof, method of immunomodulation |
Country Status (20)
Country | Link |
---|---|
US (2) | US5441976A (en) |
EP (1) | EP0532595B1 (en) |
JP (1) | JP3204320B2 (en) |
KR (1) | KR100236253B1 (en) |
AT (1) | ATE144705T1 (en) |
AU (1) | AU652946B2 (en) |
CA (1) | CA2083274C (en) |
DE (1) | DE69122961T2 (en) |
DK (1) | DK0532595T3 (en) |
HK (1) | HK62597A (en) |
HU (1) | HU215920B (en) |
IE (1) | IE80754B1 (en) |
IL (1) | IL98310A (en) |
LV (2) | LV10186B (en) |
NO (1) | NO924723D0 (en) |
NZ (1) | NZ247658A (en) |
PT (1) | PT97905B (en) |
RU (1) | RU2119793C1 (en) |
SG (1) | SG49736A1 (en) |
WO (1) | WO1991018594A1 (en) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9018994D0 (en) * | 1990-08-31 | 1990-10-17 | Secr Defence | Toxic agent protective compounds |
US5889050A (en) * | 1991-06-21 | 1999-03-30 | Astra Aktiebolag | 3,3'-dithiobis (propionic acids) and esters thereof |
SE9103572D0 (en) * | 1991-11-29 | 1991-11-29 | Astra Ab | ORGANIC SALTS OF N, N'-DIACETYL CYSTINE |
JP2947044B2 (en) * | 1993-01-27 | 1999-09-13 | 味の素株式会社 | Adjuvant therapy for immunodeficiency syndrome treatment |
DE4329857C2 (en) * | 1993-09-03 | 1995-08-24 | Deutsches Krebsforsch | Connection to strengthen the immune system and immune reactions |
SE9500897D0 (en) * | 1995-03-14 | 1995-03-14 | Astra Ab | The pharmacological use of certain cysteine derivatives |
SE9501067D0 (en) * | 1995-03-24 | 1995-03-24 | Astra Ab | New peptides |
SE9602262D0 (en) * | 1996-06-06 | 1996-06-06 | Astra Ab | New use of cystine derivatives |
US20030203006A1 (en) * | 1997-10-29 | 2003-10-30 | Ajinomoto Co. Inc. | Immunomodulator |
US6197749B1 (en) | 1997-10-29 | 2001-03-06 | Ajinomoto Co., Inc. | Method of suppressing immune responses by reducing intracellular content of glutathione in macrophages and monocytes |
EP1120407B1 (en) | 1998-10-09 | 2013-02-20 | Ajinomoto Co., Inc. | Cystine derivatives |
EP1004302A3 (en) * | 1998-10-29 | 2003-06-04 | Ajinomoto Co., Inc. | Immunomodulator |
SE9900438D0 (en) * | 1999-02-10 | 1999-02-10 | Astra Ab | The pharmacological use of certian cystine derivatives |
JP3988014B2 (en) * | 2000-02-02 | 2007-10-10 | 味の素株式会社 | Antiviral agent |
PT2283817T (en) | 2000-11-30 | 2016-08-22 | Vectura Ltd | Method of making particles for use in a pharmaceutical composition |
SE518784C2 (en) * | 2000-12-27 | 2002-11-19 | Nactilus Ab | "N-Acetyl-L-Cysteine with Compositions for the Treatment of Neoplasms" |
US8530509B2 (en) | 2003-06-20 | 2013-09-10 | Siga Technologies, Inc. | Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases |
DE102004043055B4 (en) | 2004-09-06 | 2009-04-02 | Siemens Ag | Guide device for guiding a movable machine element of a machine |
WO2008066603A2 (en) * | 2006-10-03 | 2008-06-05 | Galleon Pharmaceuticals, Inc. | S-nitrosothiol compounds and related derivatives |
MX348481B (en) * | 2007-04-23 | 2017-06-15 | Siga Tech Inc | Chemicals, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases. |
US7829709B1 (en) | 2007-08-10 | 2010-11-09 | Marquette University | Cysteine prodrugs to treat schizophrenia and drug addiction |
JP5796881B2 (en) * | 2008-02-07 | 2015-10-21 | マーケット ユニバーシティー | Cysteine and cystine prodrugs to treat schizophrenia and reduce drug craving |
JP6458809B2 (en) | 2014-04-25 | 2019-01-30 | 味の素株式会社 | Immunostimulator |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR8205M (en) * | 1968-12-20 | 1970-09-14 | ||
US3878305A (en) * | 1972-05-25 | 1975-04-15 | Procter & Gamble | Fortification of foodstuffs with n-acyl derivatives of sulphur-containing l-amino acids |
US3952115A (en) * | 1975-04-02 | 1976-04-20 | The Procter & Gamble Company | Fortification of foodstuffs with N-acyl derivatives of sulfur-containing L-amino acid esters |
FR2503151A1 (en) * | 1981-04-02 | 1982-10-08 | Morelle Jean | Compsns. contg. N-butyryl alpha-aminoacid(s) - for cosmetic, hygienic, therapeutic or agricultural use |
GB2097256B (en) * | 1981-04-02 | 1985-05-30 | Morelle Jean V | Compositions containing n-butyryl alphaaminoacids |
US4827016A (en) * | 1985-09-16 | 1989-05-02 | Morgan Lee R | Method and compounds for reducing dermal inflammations |
US4724239A (en) * | 1985-09-16 | 1988-02-09 | Morgan Lee R | Method of treating chemical ulcers with N,N'-diacetylcystine, N-acetyl homocysteine and N-acetyl cysteine |
US4708965A (en) * | 1985-09-16 | 1987-11-24 | Morgan Lee R | Method of treating herpes virus infections with N,N'-diacetylcystine and derivatives |
IT1249650B (en) * | 1991-05-29 | 1995-03-09 | Poli Ind Chimica Spa | N- (5-TIOXO-L-PROLIL) -L-CISTEIN AND ITS DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC USE |
-
1991
- 1991-05-30 IL IL9831091A patent/IL98310A/en not_active IP Right Cessation
- 1991-06-03 KR KR1019920703125A patent/KR100236253B1/en not_active IP Right Cessation
- 1991-06-03 EP EP91910813A patent/EP0532595B1/en not_active Expired - Lifetime
- 1991-06-03 AU AU80941/91A patent/AU652946B2/en not_active Ceased
- 1991-06-03 SG SG1996004501A patent/SG49736A1/en unknown
- 1991-06-03 RU RU92016463A patent/RU2119793C1/en not_active IP Right Cessation
- 1991-06-03 WO PCT/SE1991/000388 patent/WO1991018594A1/en active IP Right Grant
- 1991-06-03 DE DE69122961T patent/DE69122961T2/en not_active Expired - Fee Related
- 1991-06-03 HU HU9203871A patent/HU215920B/en not_active IP Right Cessation
- 1991-06-03 JP JP51096391A patent/JP3204320B2/en not_active Expired - Fee Related
- 1991-06-03 AT AT91910813T patent/ATE144705T1/en not_active IP Right Cessation
- 1991-06-03 CA CA002083274A patent/CA2083274C/en not_active Expired - Fee Related
- 1991-06-03 DK DK91910813.4T patent/DK0532595T3/en active
- 1991-06-07 IE IE194591A patent/IE80754B1/en not_active IP Right Cessation
- 1991-06-07 PT PT97905A patent/PT97905B/en not_active IP Right Cessation
-
1992
- 1992-12-04 US US07/949,648 patent/US5441976A/en not_active Expired - Lifetime
- 1992-12-07 NO NO924723A patent/NO924723D0/en unknown
-
1993
- 1993-05-20 NZ NZ247658A patent/NZ247658A/en unknown
- 1993-08-06 LV LVP-93-1017A patent/LV10186B/en unknown
-
1995
- 1995-06-01 US US08/457,004 patent/US5780508A/en not_active Expired - Fee Related
-
1997
- 1997-05-08 HK HK62597A patent/HK62597A/en not_active IP Right Cessation
- 1997-10-30 LV LVP-97-219A patent/LV11985B/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU92016463A (en) | APPLICATION OF DERIVATIVES OF TISSTINES FOR THE MANUFACTURE OF MEDICINES WITH IMMUNOMODING EFFECT, PHARMACEUTICAL COMPOSITIONS ON THEIR BASIS | |
BG101118A (en) | Therapeutical compounds | |
ATE210127T1 (en) | 6-SUBSTITUTED MYCOPHENOLIC ACID DERIVATIVES WITH IMMUNE SUPPRESSIVE EFFECTS | |
ES2137948T3 (en) | ADVANCED SYSTEM OF ADMINISTRATION OF MEDICINES AND METHOD OF TREATMENT OF PSYCHIATRIC, NEUROLOGICAL AND OTHER DISORDERS WITH CARBAMACEPINE. | |
IL91276A0 (en) | Pharmaceutical compositions containing alpha-amino boronic acid derivatives,for the prophylaxis and treatment of virus diseases | |
DE68929388D1 (en) | Anticoagulant compound isolated from urine | |
IT8322855A0 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PERIPHERAL ARTERIAL DISEASE. | |
IT8619055A0 (en) | PHARMACEUTICAL COMPOSITIONS INCLUDING PEPTIDES OF THE CHOLECYSTOKININ-CERULIN GROUP FOR THE THERAPEUTIC TREATMENT OF SHOCK STATES AND RESPIRATORY AND CARDIOCIRCULAR INSUFFICIENCY. | |
IT8009551A0 (en) | E-5-(2-HALOGENOVINIL-)-2'DEOXYCYTIDINES, THEIR METHOD OF PREPARATION AND THEIR USE FOR THE TREATMENT OF VIRUS DISEASES | |
NO165071C (en) | ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 7- (3-AMINO-1-PYRROLIDINYL) -8-CHLORO-1-CYCLOPROPYL-6-FLUORO-1,4, -DIHYDRO-4-OXO-3-CHINOLINE-CARBOXYL. | |
ATA99191A (en) | MEDICINAL PRODUCT PROTEIN C | |
ES2089286T3 (en) | NEW 2-AMINO-5-CIANO-1,4-DIHIDROPIRIDINAS, PROCEDURE FOR ITS PREPARATION AND USE IN MEDICINES. | |
ATE5256T1 (en) | PHENYLPIPERAZIN DERIVATIVES OF 1,3,4OXADIAZOLYLPENOLS, THEIR PREPARATION AND THERAPEUTIC AGENTS CONTAINING THEM. | |
ATE27157T1 (en) | CYCLOALKYL DERIVATIVES OF BENZISOSELENAZOLONES, PROCESS FOR THEIR PRODUCTION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM. | |
DE3380923D1 (en) | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DISORDERS CONDITIONED BY HUMAN DRUGS. | |
OA07270A (en) | N- (vinblastinoyl-23) amino acid derivatives, their preparation and therapeutic application. | |
ATE28566T1 (en) | CELL-TOXIC MEDICINAL PRODUCT CONTAINING AT LEAST AN IMMUNOTOXIN AND AN AMINE. | |
ES2060440T3 (en) | DERIVATIVES OF 1,4-DIHIDROPIRIDIN-DICARBOXILICOS ACIDS ARIL-QUINOLIL SUBSTITUTED, PROCEDURE FOR ITS MANUFACTURE AND ITS USE IN MEDICINES. | |
DE68905076D1 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF SKIN Wounds. | |
ES2160927T3 (en) | PHARMACEUTICAL COMPOSITIONS THAT INCLUDE INTERFERED NATURAL HUMAN ALPHA. | |
DE3064854D1 (en) | Quail-egg lyophilisate for the treatment of immuno-allergic diseases | |
SE8802323D0 (en) | 8ALFA-ACYLAMINOERGOLINE, ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT | |
RU93052408A (en) | ACYLAMINO-ALKYLIDENE-HYDROXY-BIS-PHOSPHONE ACIDS, METHOD FOR THEIR PRODUCTION, PHARMACEUTICAL COMPOSITION | |
EP0038153A3 (en) | Modified allergens | |
IT1246050B (en) | USE OF HEPTASTIGMIN IN CEREBRAL STROKE THERAPY. |